Emulsion Polymer Market To Benefit from Increased Global Uptake of 2024 By 2030

 Emulsion Polymer Market Growth & Trends

The global emulsion polymer market size is anticipated to reach USD 49.35 billion by 2030 and it is projected to grow at a CAGR of 6.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing construction activities across the world and growing application of emulsion polymers in the paint and coatings industry are driving the market.

Polymer emulsion is in high demand in a variety of industries because of its unique features, environmental benefits, and versatility of application. This increased need is attributed to a greater emphasis on environmental standards, and sustainability has resulted in a move to water-based systems in businesses that formerly relied on solvent-based formulations. Furthermore, polymer emulsions are used in the construction industry for applications such as waterproofing, cement modification, and surface treatments, which contributes to increased demand.

The increasing awareness among consumers of paint concepts and protective coatings, as well as the developing trend in interior decor, are driving the expansion of the emulsion resin market. Another factor driving market growth is the growing usage of paints and coating solutions in the automobile industry. Furthermore, customer demand for ecologically friendly products that provide a safe and healthy environment has increased global demand for water-based polymer emulsions. Population expansion is a result of global urbanization, which is likely to boost the need for housing, resulting in growing demand for end-user commodities.

Request a free sample copy or view report summary: Emulsion Polymer Market Report

Emulsion Polymer Market Report Highlights

• Based on type, acrylic polymer dominated the type segment with more than 41.0% share in 2023 owing to increasing demand for high-performance materials, the need for lightweight and durable materials, and growth in end-use industries
• Based on application, the paint & coatings application segment is expected to grow at the fastest CAGR over the forecast period
• Based on end-use, the building & construction segment held the largest market share of 37.7% in 2023. This growth can be attributed worldwide infrastructure development and increasing commercial and residential sector
• The rise in residential and commercial construction projects due to the growing housing needs and notable growth opportunities prevailing in the market
• Asia Pacific dominated the market owing to the increased investment in construction projects, a growing middle class, improved lifestyles and increased purchasing power of consumers
• In October 2023, BASF launched line of emulsions for architectural coatings in North America. These emulsion polymers offer the same quality and performance as existing Acronal products but have the added benefit of reducing carbon emissions

Access Press Release@ https://www.grandviewresearch.com/press-release/emulsion-polymer-market-report

Emulsion Polymer Market Segmentation

Grand View Research has segmented the global emulsion polymer market based on type, application, end-use, and region:

Emulsion Polymer Type Outlook (Revenue, USD Million, 2018 - 2030)

• Acrylics
• Styrene-Butadiene Latex
• Vinyl Acetate Polymers
• Other

Emulsion Polymer Application Outlook (Revenue, USD Million, 2018 - 2030)

• Paints and Coatings
• Adhesives & Sealants
• Paper & Paperboard
• Others

Emulsion Polymer End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Building & Construction
• Automotive
• Chemicals
• Textile & Coatings
• Others

Emulsion Polymer Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Southeast Asia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players in the Emulsion Polymer Market

• Synthomer
• OMNOVA Solutions
• Allnex GMBH
• Arkema
• DIC CORPORATION
• BASF SE
• Celanese Corporation
• Wacker Chemie AG
• Momentive
• Mallard Creek Polymers
• Solvay
• Clariant
• Asahi Kasei Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Property And Casualty Insurance Market Continues to Grow

 Property And Casualty Insurance Market Growth & Trends

The global property and casualty insurance market is anticipated to reach USD 6,180.14 billion by 2030 and is anticipated to expand at a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Technological progress, rapidly evolving consumer behavior and the intricate nature of purchasing insurance have prompted property & casualty insurance providers to explore embedded insurance offerings seamlessly into their business framework, particularly for personal and small commercial lines.

For instance, as per the World Insurtech Report 2021, traditional insurers are adopting novel business models, with at least half of their customers showing a willingness to purchase insurance, encompassing embedded products provided by product manufacturers, BigTech companies, and InsurTech startups. These factors are expected to propel market expansion in the foreseeable future.

The integration of advanced technologies, such as artificial intelligence and machine learning, into underwriting processes, is also contributing to the growth of the market. Insurers are increasingly leveraging data analytics to assess risk more accurately, optimize pricing models, and enhance overall decision-making. This technology-driven evolution not only streamlines operational efficiency but also enables insurers to better adapt to changing risk profiles in an ever-evolving environment.

Another significant trend involves the increasing demand for personalized insurance solutions. Consumers are seeking tailored coverage that aligns with their unique needs and lifestyles. Insurers are responding by leveraging data insights and customer-centric technologies to craft more bespoke policies. This shift towards personalized insurance not only fosters customer satisfaction but also positions insurers to better manage risks by aligning coverage with specific customer characteristics and behaviors. As the property and casualty insurance market continues to evolve, these trends underscore the industry's commitment to innovation and responsiveness to evolving consumer expectations.

Request a free sample copy or view report summary: Property And Casualty Insurance Market Report

Property And Casualty Insurance Market Report Highlights

• In terms of product, homeowners insurance dominated the product type segment in 2023. Homeowners insurance is used to safeguard homes and possessions, ensuring financial protection against unforeseen risks and meeting mortgage lender requirements
• Based on the distribution channel, the brokers distribution channel segment held the largest market share in 2023. Brokers bridge the insurers and customers, offering expertise, customization, and simplification of insurance processes for enhanced accessibility and tailored coverage
• Based on end-user, the individuals segment dominated the end user segment owing to the rising need for financial security and comprehensive coverage against unforeseen events, safeguarding homes, belongings, and personal liability
• North America dominated the market as consumers are seeking personalized, technology-driven insurance solutions that utilize advanced data analytics for more accurate risk assessment and streamlined processes, ensuring tailored coverage and enhanced overall satisfaction
• In October 2023, First Street Foundation, a non-profit organization committed to providing accessible climate risk information, announced its first partnership with American Family Insurance, a prominent property and casualty insurance company. Through this partnership, American Family, a mutual insurance company headquartered in Madison, Wisconsin, would provide its exclusive agency force with access to First Street's property-specific data for homes across the U.S. This includes information from First Street Foundation's models on flood, wildfire, extreme heat, and future perils

Access Press Release@ https://www.grandviewresearch.com/press-release/global-property-casualty-insurance-market

Property And Casualty Insurance Market Report Segmentation

Grand View Research has segmented the global property & casualty insurance market based on product type, distribution channel, end-user, and region:

Property & Casualty Insurance Product Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Homeowners Insurance
• Renters Insurance
• Condo Insurance
• Landlord Insurance
• Others

Property & Casualty Insurance Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2030)

• Tied Agents and Branches
• Brokers
• Others

Property & Casualty Insurance End-user Outlook (Revenue, USD Billion, 2017 - 2030)

• Individuals
• Governments
• Businesses

Property & Casualty Insurance Region Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • Kingdom of Saudi Arabia (KSA)
  • UAE
  • South Africa

List of Key Players in the Property And Casualty Insurance Market

• State Farm Mutual Automobile Insurance Company
• Berkshire Hathaway Specialty Insurance
• Progressive Casualty Insurance Company
• Allstate Insurance Company
• Chubb
• Liberty Mutual Insurance Company
• The Travelers Indemnity Company
• USAA Insurance Company
• CNA Financial Corp.
• Farmers Insurance Group of Companies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Polyetheretherketone Market Is Expected To Accomplish A Valuation Of Around $1,003.25 Million By 2030: Grand View Research Inc.

 Medical Polyetheretherketone Market Growth & Trends

The global medical polyetheretherketone market size is expected to reach USD 1,003.25 million by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at CAGR of 7.4% over the forecast period. The demand can be attributed to the increasing adoption of medical polyetheretherketone (PEEK) for use in medical implants such as knee & hip implants, vascular medical devices, spinal implants, and dental fixtures.

The market is expected to register growth due to the high adoption of the product on account of its superior chemical inertness, heat and superior fatigue resistance. However, the high cost of the polyetheretherketone compared to other plastics may hinder the market growth over the forecast period.

Rise in global healthcare expenditure and replacement of metals with polyetheretherketone (PEEK) are the major factors contributing to the growth of the market. Healthcare spending in the country is likely to accelerate in the near future owing to the growing awareness about healthcare. Factors such as rising needs of the geriatric population (65 years of age or above), an increase in the prevalence of chronic disorders & diseases, infrastructure improvements, and technological advancements are expected to drive the healthcare sector, thereby leading to an increase in the demand for medical medical-grade PEEK.

PEEK has many advantages over metals like titanium or stainless steel in medical applications. PEEK can be used to produce innovative interbody fusion cages. These can be designed with microporous structures and can be further enhanced with hydroxyapatite or zeolite, which naturally promote bone growth. PEEK is chemically inert and is preferred over metals in areas where the reaction of chemicals with metals is not fully understood. PEEK is also preferred for medical devices as it reduces the weight of the device. Due to its radiopacity, PEEK is preferred as certain scanning devices cannot scan through metallic parts. Finally, because of its high-temperature resistance, tools made of PEEK can be easily sterilized by autoclaving and reused many times.

Another added advantage is that PEEK can be 3D printed to produce patient-specific designs and porous geometries ideal for stable integration with bone. PEEK polymers can be 3D printed to make ergonomic, strong, and light tools and can be used as reusable surgical instruments. These can reduce surgeon fatigue and thus prevent potentially harmful mistakes during long surgeries. PEEK tools, because of their radiopacity, do not interfere with the surgeon’s view for minimally invasive surgeries, live x-ray imaging, or guided by fluoroscopy, unlike metal tools.

Request a free sample copy or view report summary: Medical Polyetheretherketone Market Report

Medical Polyetheretherketone Market Report Highlights

• Spine implantation was the largest application segment in 2023, driven by high-volume consumption of polyetheretherketone in the manufacturing of spinal cages or spacers. These are used for patients suffering from degenerative spondylolisthesis, degenerative disk disease, spinal stenosis, and degenerative scoliosis, among other deformities of the spine.
• The demand for polyetheretherketone in spine implantation is expected to remain high due to the superior properties of this plastic, including high flexural strength, radiopacity, similar bone modulus, impact resistance, and lightness, as compared to metals like titanium. Furthermore, the growing elderly population in countries such as the U.S., Italy, and Japan is likely to propel the demand for polyetheretherketone in spine implants.
• PEEK is witnessing growing demand in spinal interbody fusion implants. Spinal procedures are categorized by implant type and the region of the spine where they are applied. Spinal implants include interbody devices, plates, pedicle screws, and rod fixation systems. Interbody fusion procedures, cervical fixation, and thoracolumbar fixation were found to be the most commonly performed spinal procedures.
• Processing of PEEK is time-consuming. For example, polytetrafluoroethylene (PTFE) can be molded using cold compression and can be put into a sintering oven in batches. On the contrary, PEEK has to be sintered during the compression stage itself and needs to be annealed, which is a time-consuming process.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-polyetheretherketone-peek-market

Medical Polyetheretherketone Market Segmentation

Grand View Research has segmented the global medical polyetheretherketone market on the basis of application, and region:

Medical Polyetheretherketone Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Trauma Fixation
• Cardiovascular
• Orthopaedic
  • Spine Implantation
  • Knee & Hip Implantation
• Dental Implants & Fixtures
• Others

Medical Polyetheretherketone Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Netherlands
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Thailand
  • Vietnam
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates (UAE)
  • South Africa

List of Key Players in the Medical Polyetheretherketone Market

• Superior Polymers
• Evonik Industries AG
• Invibio Ltd.
• Solvay
• Medtronic
• Victrex plc
• Ensinger
• Boedeker Plastics, Inc.
• Röchling
• PEEKCHINA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Meditation Management Apps Market Expected to Collect $4.97 Billion by the End of 2030: Grand View Research Inc.

 Meditation Management Apps Market Growth & Trends

The global meditation management apps market size is expected to reach USD 4.97 billion by 2030 and is expected to expand at a CAGR of 18.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing healthcare expenditure, surge in innovations and technologies, and growing prevalence of mental disorders such as anxiety and depression fuel market growth. For instance, in May 2023, as per a Gallup survey, 29.0% of Americans reported being diagnosed with depression in their lifetime, while 17.8% had or were undergoing treatment for depression at that point.

Rising funding opportunities for developing various meditation and mental health apps signify market growth opportunities. For instance, Revenue and Usage Statistics for Calm, which offers guided meditation apps, published by Business of Apps, stated that Calm had received USD 28 million in 2018 in funding and this value increased to USD 218 million in 2020. This substantial rise in funding is expected to drive market growth over the forecast period.

In addition, with widespread use of smartphones and availability of advanced technologies, investors are investing in developing innovative solutions for delivering high-quality meditation management apps. These platforms enable patients to monitor their moods and listen to natural sounds, helping in reducing anxiety and stress management through meditation. For instance, the Aura app allows users to create gratitude journals and monitor their user's moods.

Request a free sample copy or view report summary: Meditation Management Apps Market Report

Meditation Management Apps Market Report Highlights

• iOS segment dominated the global market in 2023 with a revenue share of 48.9%, due to increasing adoption of iPhones among consumers
• By deployment type, cloud-based segment dominated the global market with largest revenue share in 2023
• In terms of services, free applications held the largest market revenue share in 2023. Free services offer walking meditations, fuss-free meditation timers with a gentle bell sound, and guided meditation series based on individual mood and health concerns
• North America dominated the overall market in 2023 with a revenue share of 36.9%, owing to the rapidly developing healthcare IT infrastructure, emergence of startups, growing funding options, and improving technological literacy in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-meditation-management-apps-market

Meditation Management Apps Market Segmentation

Grand View Research has segmented the global meditation management apps market based on platform, deployment type, services, and region:

Meditation Management Apps Platform Outlook (Revenue, USD Million, 2018 - 2030)

• iOS
• Android
• Others

Meditation Management Apps Deployment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Cloud-based
• On-premise

Meditation Management Apps Services Outlook (Revenue, USD Million, 2018 - 2030)

• Free
• Paid (In App Purchase)

Meditation Management Apps Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

List of Key Players in Meditation Management Apps Market

• Inner Explorer
• Calm
• Headspace Inc.
• MindApps
• Breethe
• Meditation Moments
• Simple Habit
• Ten Percent Happier
• Aura Health
• Meditopia

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cleaning And Hygiene Products Market to Expand at a CAGR of 6.5% Through 2030: Grand View Research Inc.

 Cleaning And Hygiene Products Market Growth & Trends

The global cleaning and hygiene products market size is anticipated to reach USD 233.43 billion by 2030 and it is projected to expand at a CAGR of 6.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness of hygiene due to global health concerns and growing emphasis on cleanliness in public spaces are driving the demand for cleaning & hygiene products. Additionally, innovations in eco-friendly and sustainable product offerings are contributing to market expansion.

The COVID-19 pandemic significantly elevated hand hygiene awareness, prompting widespread adoption of regular handwashing and increased use of hand sanitizers. A study published in September 2022 by Citron Hygiene in collaboration with One Poll found that before the pandemic, only 11% of people washed their hands for the recommended 18 to 20 seconds; during the pandemic, that rose to 25%. People have been washing their hands more regularly when going out, especially before and after eating, visiting common areas, and cleaning their homes.

This heightened emphasis on hygiene positively impacts the market for hygiene products, leading to increased demand and growth opportunities. The pandemic led to a surge in the adoption of products like sanitizers and disinfectants, as heightened hygiene awareness prompted widespread use for personal and public health safety. This trend has prompted market players to ramp up production capacities in response to heightened consumer demand.

Unilever, for example, significantly expanded its third-party manufacturers from two to approximately fifty-seven within a five-month period during the pandemic. Its factory in Vietnam led the way by swiftly transitioning its production to hand sanitizers in just 25 days. The market is anticipated to witness rapid growth during the forecast period, driven by increasing environmental apprehensions surrounding the toxic components present in cleaning products.

A 2022 survey by CloroxPro, encompassing nearly 1,200 respondents, revealed that 81% expressed a preference for public spaces employing eco-conscious cleaners, citing environmental benefits as the primary reason. In September 2022, CloroxPro announced the launch of Clorox EcoClean, its latest line of professional cleaning products, certified by the Environmental Protection Agency and U.S. Department of Agriculture. The line included a ready-to-use disinfectant cleaner, all-purpose cleaner, and glass cleaner.

Manufacturers have been adopting strategies such as, new product launch, partnerships, and mergers to gain significant market share and to reach new audience. For instance, In April 2021, Godrej Consumer Products Ltd. (GCPL) introduced a new 2-in-1 liquid detergent within its Ezee brand lineup in India. Designed for both washing machines and handwashing, this product aims to diversify GCPL's liquid detergent range and enter the everyday cloth detergent segment, reducing dependency on seasonal sales patterns.

Request a free sample copy or view report summary: Cleaning And Hygiene Products Market Report

Cleaning And Hygiene Products Market Report Highlights

• Based on product, detergents & degreasers dominated the market owing to rising demand for eco-friendly and biodegradable detergents and degreasers, as consumers prioritize environmentally conscious products
• Based on application, laundry dominated the market owing to increased awareness regarding the benefits of wearing clean clothes
• Based on end-use, commercial cleaning & hygiene products are expected to witness fastest growth through 2030 due to the rising number of restaurants, hotels, and hospitals across regions, which has been significantly contributing to the demand for various commercial cleaning products to maintain a clean and hygienic environment
• Asia Pacific is projected to emerge as a lucrative market for cleaning & hygiene products. This can be attributed to the growing middle class population, increasing disposable income, and popularity of cleaning & hygiene products in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cleaning-hygiene-products-market

Cleaning And Hygiene Products Market Report Segmentation

Grand View Research has segmented the globalcleaning and hygiene products market based on product, application, end-user, and region:

Cleaning & Hygiene Product Outlook (Revenue, USD Million, 2018 - 2030)

• Abrasives
• Acids
• Bleaches
• Detergents & Degreasers
• Sanitizers     
• Others

Cleaning & Hygiene Products Application Outlook (Revenue, USD Million, 2018 - 2030)

• Toilet
• Kitchen
• Floor
• Surface
• Laundry
• Hand/Personal Care
• Others

Cleaning & Hygiene Products End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Household
• Commercial
  • Hospitals & Healthcare Establishments
  • Hospitality
  • Food Service
  • Cruise Ships
  • Building Service Contractors
  • Retail Stores
  • Institutional
  • Commercial Laundry

Cleaning & Hygiene Products Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Poland
  • Belgium
  • Switzerland
• Asia Pacific
  • China
  • India
  • Australia & New Zealand
  • South Korea
  • Indonesia
  • Thailand
  • Malaysia
• Central & South America
  • Brazil
  • Argentina
  • Caribbean Islands
  • Central America
• Middle East & Africa
  • Turkey
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria

List of Key Players in Cleaning And Hygiene Products Market

• Colgate-Palmolive Company
• The Procter & Gamble Company
• Henkel AG & Co. KGaA
• Unilever plc
• Reckitt Benckiser Group plc
• Church & Dwight Co., Inc.
• Kao Corporation
• C. Johnson & Son Inc.
• McBride plc
• Vikara Services Pvt. Ltd. (The Better Home)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare IT Market Is Projected To Reach Approximately $1,834.3 Billion By 2030: Grand View Research Inc.

 

Healthcare IT Market Growth & Trends

The global healthcare IT market size is expected to reach USD 1,834.3 billion by 2030, growing at a CAGR of 15.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising demand for advanced healthcare IT solutions, including Electronic Health Record (EHR), along with increased smartphone usage and the need for remote patient monitoring for improved out-of-hospital care are driving the overall growth.

For instance, a 2021 article in the Journal of Medical Internet Research titled 'Adoption of EHRs in China over the Past Decade: A Comparative Study with the U.S.' highlights the increasing adoption of EHRs in both the U.S. and China. However, adoption rates vary due to different strategies at the country level. Hospitals in the U.S. and China showed 9.6% and 6.1% adoption rates, respectively. Notably, 534 hospitals in the U.S. adopted EHRs annually on average. In China, the number was significantly higher at 1,500, indicating the need for a greater effort.

A rise in healthcare spending across the globe is driving the demand for the implementation of IoT solutions in the healthcare sector. According to the estimates published by the World Health Organization (WHO) in 2020, global healthcare spending witnessed a significant surge, accounting for 11% (USD 9 trillion) of the global GDP. The healthcare industry is evolving from a fee-for-service model to a value-based model, wherein treatment outcomes are reimbursed. The pressure of reducing healthcare costs is rising globally, as the cost of healthcare is increasing faster than economic growth.

Advancements in healthcare IT are providing opportunities to cut down healthcare spending by improving care delivery and clinical outcomes. Best possible interventions enabled through timely data aggregation coupled with an increase in patient involvement for the management of chronic care through patient engagement portals are among the factors contributing to cost reduction. IoT-enabled clinical trials also offer an opportunity for cost reduction as IoT simplifies the overall process and captures sophisticated endpoints. Remote patient monitoring solutions help in handling non-critical patients at home, which eventually reduces hospital admissions and improves workflow efficiency. In addition, IoT solutions also enhance clinical operations through asset tracking and improvement in data capturing help in significant cost savings.

Market players are focusing on innovative product development strategies. Notable players are integrating big data, Internet of Things (IoT), Artificial Intelligence (AI), and Machine Learning (ML) algorithms in their existing solutions to enhance health & medical processes, which is fueling the market growth. For instance, in April 2023, eClinicalWorks announced the integration of its Practice Management and EHR solutions with cognitive services, including ChatGPT and machine learning models from Azure OpenAI Service, to enhance its technology offerings. This strategic move followed eClinicalWorks' significant USD 100 million investment in Microsoft Azure cloud services, allowing the company access to the latest innovations within the Microsoft Cloud ecosystem.

Request a free sample copy or view report summary: Healthcare IT Market Report

Healthcare IT Market Report Highlights

• Based on application, the electronic prescribing systems segment is expected to exhibit the fastest CAGR of 26.8% from 2024 to 2030. An increase in awareness of the advantages of e-prescribing is fueling the adoption of e-prescribing systems
• North America dominated with a revenue share of 40.0% in 2023. This growth is fueled by the extensive adoption of healthcare IT solutions and services, especially in the U.S., as providers strive to enhance patient care while reducing costs
• Asia Pacific is anticipated to grow at the fastest CAGR of 22.0% from 2024 to 2030, due to the high demand for healthcare IT services, owing to increased government spending on healthcare

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-it-market

Healthcare IT Market Segmentation

Grand View Research has segmented the global healthcare IT market based on application, delivery mode, end use and region:

Healthcare IT Application Outlook (Revenue, USD Million, 2018 - 2030)

• Computerized Provider Order Entry Systems
• Electronic Prescribing Systems (E-Prescribing Solutions)
• Laboratory Information
• Clinical Information Systems
• Regulatory Information Management (RIM) Systems
• Medical Imaging Information Systems
  • Radiology Information Systems
  • Monitoring Analysis Software
  • Picture Archiving and Communication Systems
• Electronic Health Records
  • Licensed Software
  • Technology Resale
  • Subscriptions
  • Professional Services
  • Others
• Tele-healthcare
  • Tele-care
  • Tele-Health
• Revenue Cycle Management
  • Integrated
  • Standalone
• eClinical Solutions
  • Electronic Clinical Outcome Assessment (eCOA)
  • Electronic Data Capture (EDC) & CDMS
  • Clinical Analytics Platforms
  • Clinical Data Integration Platforms
  • Safety Solutions
  • Clinical Trial Management System (CTMS)
  • Randomization and Trial Supply Management (RTSM)
  • Electronic Trial Master File (eTMF)
  • eConsent
• Population Health Management (PHM)
• Digital Healthcare Supply Chain Management
  • Software
  • Hardware
    • Barcodes
    • RFID Tags
  • Services
• Clinical alarm management
  • Nurse Call Systems
  • Physiological Monitors
  • Bed Alarms
  • EMR Integration Systems
  • Ventilators
  • Others
• Healthcare Customer relationship management (CRM)
  • Customer Service and Support
  • Digital Commerce
  • Marketing
  • Sales
  • Cross -CRM
• Technology Solutions in the Healthcare Payers
  • Enrollment and Member Management
  • Provider Management
  • Claims Management
  • Value based Payments
  • Revenue Management and Billing
  • Analytics
  • Personalize/CRM
  • Clinical Decision Support
  • Data management and support
  • Others
• Healthcare Analytics
  • Descriptive Analysis
  • Predictive Analysis
  • Prescriptive Analysis

Healthcare IT Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Solutions
  • Software
    • On-Demand/On-premise
    • Cloud-based/ Web-based
  • Services
• Hardware

Healthcare IT End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Healthcare Providers
  • Hospitals & Clinics
  • Home Care Settings
  • Outpatient Facilities
    • Ambulatory surgery centers (ASCs)
    • Physician’s Clinic
    • Others (Laboratories, Pharmacy, etc.)
  • Long-term Care Facilities
  • Specialty Centers
• Healthcare Payers
  • Government
  • Commercial
• Life Sciences Industry
  • Pharma & Biotech Organizations
  • Medical Device Manufacturers
  • Contract Research Organizations (CROs)
  • Academic institutes

Healthcare IT regional Outlook by (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Sweden
  • Denmark
  • Norway
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

 List of Key Players in the Healthcare IT Market

• Philips Healthcare
• McKesson Corporation
• eMDs, Inc.
• Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.)
• Athenahealth, Inc. (Acquired by Hellman & Friedman and Bain Capital)
• Carestream Health
• GE Healthcare
• Agfa- Gevaert Group
• Hewlett Packard Enterprise Development LP
• Novarad
• Optum, Inc.
• IBM
• Oracle
• SAS Institute, Inc.
• IQVIA
• Verisk Analytics, Inc.
• Cerner Corporation
• SAP
• Accenture

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Peptide And Oligonucleotide CDMO Market Trends, Demand, Production, Analysis and Forecast to 2030: Grand View Research Inc.

 Peptide And Oligonucleotide CDMO Market Growth & Trends

The global peptide and oligonucleotide CDMO market is expected to reach USD 5.67 billion by 2030, according to a new report by Grand View Research, Inc. , registering a CAGR of 12.5% from 2024 to 2030. The growing recognition of peptides and oligonucleotides as valuable therapeutic agents for various diseases is fueling the demand for CDMO services. Moreover, the increasing pipeline of peptides and oligonucleotide therapeutics and the growing penetration of CDMOs in the field are a few of the factors driving the growth of the market.

The market is fragmented, with several players having similar technological and processing capabilities. These companies offer various services related to peptide and oligonucleotide development, data interpretation, sample analysis, and clinical trial support. The market is characterized by fierce competition driven by factors such as quality assurance, technological advancements, regulatory compliance, and the ability to offer high-value and diverse services.

The growing investment by major companies in the development and manufacturing of peptides and oligonucleotide-based therapeutics is one of the prominent factors supporting the growth of the market. For instance, in September 2023, CordenPharma announced the expansion of its commercial peptide production capabilities through the enhancement of facilities at CordenPharma Colorado, which now stands as the world's largest Solid-Phase Peptide Synthesis (SPPS) manufacturing facility. Additionally, in September 2023, CombiGene selected AmbioPharm as the CDMO partner for their peptide-based pain project, COZY01, which also involves Zyneyro.

The COVID-19 pandemic moderately impacted the market. The early stages of the COVID-19 pandemic had a notable impact on clinical trials, as a result of travel restrictions, disruptions in the supply chain, and setbacks in clinical trials. Nonetheless, it also presented prospects, notably the heightened emphasis on antiviral peptides and the swift creation of mRNA vaccines. Furthermore, there has been a substantial increase in collaborations and partnerships across biopharmaceutical companies with an aim to boost the production of peptide-based therapeutics.

Request a free sample copy or view report summary: Peptide And Oligonucleotide CDMO Market Report

Peptide And Oligonucleotide CDMO Market Report Highlights

• The peptides segment accounted for the largest share of 66.3% in 2023.The segment is driven by the growing demand for peptide-based therapeutics and the rise in the number of clinical trials involving the use of peptides.
• Based on the service type, the contract manufacturing segment accounted for the largest share of 65.0% in 2023. The substantial market share in this segment primarily results from the growing demand for outsourced manufacturing services, driven by the cost-effectiveness of outsourced manufacturing.
• Biopharmaceutical companies are anticipated to witness the highest CAGR of 13.0% across the analysis timeframe due to the increasing number of biopharmaceutical companies focusing on research and development of peptide-based drugs.
• Asia Pacific is anticipated to witness the highest CAGR of 13.4% during the forecast time frame. The substantial growth is primarily attributed to the rising trend of Western pharmaceutical companies outsourcing their manufacturing operations to emerging economies like China and India.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-peptide-oligonucleotide-cdmo-market

Peptide And Oligonucleotide CDMO Market Segmentation

Grand View Research has segmented the global peptide and oligonucleotide CDMO market based on product, service type, end use, and region:

Peptide And Oligonucleotide CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)

• Peptides
• Oligonucleotides

Peptide And Oligonucleotide CDMO Service Type Outlook (Revenue, USD Million, 2018 - 2030)

• Contract Development
• Contract Manufacturing

Peptide And Oligonucleotide CDMO End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Others

Peptide And Oligonucleotide CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.                
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Peptide And Oligonucleotide CDMO Market

• PolyPeptide Group
• STA Pharmaceutical Co. Ltd.
• Bachem
• Creative Peptides
• Aurigene Pharmaceutical Services Ltd.
• Merck KGaA
• EUROAPI
• Curia Global, Inc.
• CordenPharm
• Sylentis, S.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Live Commerce Platforms Market Key Players ,Industry Share ,Growth, And Forecast To 2030: Grand View Research Inc.

 Live Commerce Platforms Market Growth & Trends

The global live commerce platforms market size is anticipated to reach USD 3.48 billion by 2030, registering a CAGR of 21.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing demand for online shopping and more engaging & interactive shopping experiences is expected to drive market growth. An exponential rise in smartphone users and high-speed internet availability also contribute to market growth. In addition, the availability of first-party data for e-commerce companies to provide personalized shopping experiences and increasing engagement of the Gen Z population with live commerce platforms support industry growth. Live commerce platforms significantly contribute to the expansion of e-commerce. Platforms, such as Alibaba's Taobao Live and Amazon, have shown an increase in consumer engagement due to live-stream commerce.

For instance, in 2020, Alibaba's Taobao launched an application, a platform that integrates product showcasing with the ability to purchase in real-time. Incorporating augmented reality/virtual reality (AR/VR), artificial intelligence (AI), and 3D technology presents opportunities for enhancing live stream experience. Implementing AR/VR for virtual try-ons, AI-enabled personalized recommendations, and innovative interactive features can improve user engagement with the help of virtual try-ons, product visualization, interactive product demos, and in-store navigation tools. In addition, safe online transactions are crucial for live commerce; thus, a highly reliable payment system is needed to support transactions during peak processing times. A research paper published in June 2023 by KTH Royal Institute of Technology of Sweden reveals that Google's ARCore data shows a 40% adoption rate for mobile AR within the total AR mobile market.

Request a free sample copy or view report summary: Live Commerce Platforms Market Report

Live Commerce Platforms Market Report Highlights

• The apparel & fashion category segment dominated th industry with a share if 41.1% in 2023 due to the attractive attributes and interactive nature of live commerce. In October 2023, during Amazon's Great Indian Festival, more than 1,000 hours of livestreams were held on Amazon Live. Over 300 influencers assisting customers in making purchase decisions and 18 hours of live streaming helped the company achieve an all-time high viewership
• The consumer electronics segment is expected to grow at the fastest CAGR from 2024 to 2030. The market is growing in this segment due to its ability to offer real-time demonstrations and in-depth insights into technological products. The rising trend of connected homes supports smart appliance penetration globally. Electronic appliances with voice assistance and internet connectivity are widely adopted for convenient usage. In August 2021, Samsung launched India's first live online shopping platform,' Samsung Now,' and held a pre-booking event for mobile devices, such as the Galaxy Z Fold3 5G and Galaxy Z Flip3 5G
• Asia Pacific led the market in 2023. The region has shown a high internet penetration rate and widespread smartphone usage, creating several potential customers. Social media platforms have become integral to daily life, providing live commerce platforms with a direct channel to reach their target audience. According to the Statistical Report on China's Internet Development, the number of users for live streaming in China grew to 716 million as of June 2022, an increase of 12.90 million from December 2021, accounting for 68.1% of all Internet users in the country. Moreover, the user count for live-streaming e-commercehas reached 469 million, an increase of 5.33 million from the end of 2021, accounting for 44.6% of all internet users
• In August 2023, CommentSold announced a partnership with TikTok Shop that enables live commerce integration in the U.S. CommentSold merchants can now smoothly stream live events on TikTok using the CommentSold platform along with complete integrated live streaming production, sales, and communication management with TikTok Shop

Access Press Release@ https://www.grandviewresearch.com/press-release/global-live-commerce-platforms-market

Live Commerce Platforms Market Segmentation

Grand View Research has segmented the global live commerce platforms market based on category and region:

Live Commerce Platforms Category Outlook (Revenue, USD Million, 2018 - 2030)

• Apparel and Fashion
• Cosmetics & Personal Care
• Consumer Electronics
• Furnishing
• Entertainment
• Others

Live Commerce Platforms Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players in Live Commerce Platforms Market

• CommentSold
• GhostRetail, Inc.
• Firework
• ShopShops
• TalkShopLive
• Restream, Inc.
• Bambuser AB
• Livescale
• com Ltd.
• Klarna Bank AB (publ)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Atopic Dermatitis Clinical Trials Market Is Ready To Grow Globally With Phenomenal Trend Diversity by 2030

Atopic Dermatitis Clinical Trials Market Growth & Trends

The global atopic dermatitis clinical trials market is expected to reach USD 4.84 billion by 2030 and expand at a CAGR of 11.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Advancements in biotechnology and medicine, growing prevalence of atopic dermatitis, increasing investments by pharmaceutical companies in the development of novel drugs, rising partnerships and acquisitions among CROs and sponsor companies, technological advancements in clinical research, growing pipeline of atopic dermatitis products, and globalization of clinical trials are few of the factors supporting the lucrative growth of the global market during the forecast period.    

For pharmaceutical companies, innovation and easy access to clinics are critical factors. Furthermore, pharmaceutical and biopharmaceutical companies increasingly focus on developing novel drugs for treating atopic dermatitis. For instance, the U.S. FDA stated that several potential therapeutics will be launched in the coming years to treat atopic dermatitis. A few of the potential biologics likely to enter the market include Rocatinlimab by -Kyowa Kirin Co., Ltd., lebrikizumab by Eli Lilly and Company, CM310 by Keymed Biosciences, tozorakimab by AstraZeneca and several others. Hence, the increasing pipeline of therapeutics is one of the major factors augmenting market growth.

Furthermore, the increasing prevalence of atopic dermatitis is a significant catalyst propelling the market growth. Atopic dermatitis is a chronic inflammatory skin condition that has witnessed a notable rise in incidence globally, affecting individuals of all ages. In 2022, approximately 223 million individuals are coping with atopic dermatitis, per the Global Burden of Disease (GBD) 2022 report. Among them, approximately 43 million falls within the age group of 1 to 4 years. This surge in prevalence has created a compelling need for more effective and targeted treatment options. As a result, pharmaceutical companies, research institutions, and healthcare organizations are increasingly investing in clinical trials to explore novel therapeutic interventions.

Moreover, several companies are focusing on inorganic strategic initiatives such as mergers and acquisitions to enhance their position in the industry. For instance, in March 2022, Pfizer Inc. announced the acquisition of Arena Pharmaceuticals, a clinical-stage company dedicated to developing innovative potential therapies for various immuno-inflammatory diseases, including atopic dermatitis.

Request a free sample copy or view report summary: Atopic Dermatitis Clinical Trials Market Report

Atopic Dermatitis Clinical Trials Market Report Highlights

• Large molecules dominated the molecule type segment with a 53.2% share in 2023 due to the increasing pipeline of biologics penetrating the atopic dermatitis clinical trials industry.
• Interventional trials dominated the market owing to the large number of clinical trials with interventional study designs.
• Phase III category by phase segment is anticipated to hold the highest market share in 2023. This is due to the increasing number of drugs undergoing phase III studies. Moreover, the cost of phase III studies is much higher than the other phases, contributing to the largest market share.
• North America dominated the market owing to factors such as increasing the prevalence of atopic dermatitis in the region, presence of major market players in the region, government support for quality healthcare, and availability of reimbursement.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-atopic-dermatitis-clinical-trials

Atopic Dermatitis Clinical Trials Market Segmentation

Grand View Research has segmented the atopic dermatitis clinical trials market on the basis of molecule type, study design, phase and region:

Atopic Dermatitis Clinical Trials Molecule Type Outlook (Revenue, USD Million; 2018 - 2030)

• Small molecules
• Large Molecules

Atopic Dermatitis Clinical Trials Study Design Outlook (Revenue, USD Million; 2018 - 2030)

• Interventional
• Observational

Atopic Dermatitis Clinical Trials Phase Outlook (Revenue, USD Million; 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

Atopic Dermatitis Clinical Trials Region Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Atopic Dermatitis Clinical Trials Market

• Charles River Laboratories
• Imavita    
• REPROCELL Inc.
• Oncodesign services
• BIOCYTOGEN
• QIMA LTD
• Novotech
• Redoxis
• Syneos Health
• Hooke Laboratories, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.